Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT04347434
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Penza State University
- Registry
-
NCT04347434
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT04347434. Non-randomized; no masking; primary purpose treatment. Start 2020-02-12 (actual); primary completion 2027-11-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
- Acronym
- CONTRAST-2
- Condition
- Myocardial Infarction, Acute
- Condition
- Myocardial Strain
- Condition
- Arterial Stiffness
- Condition
- Quality of Life
- Intervention (Drug)
- Atorvastatin 80mg
- Lead sponsor
- Penza State University
Record details
- Record id
cardio:ct-nct04347434- Content hash
9de9c035e15a18d32888d3361725099b3454fed5aa3d4f32ccbd4b45784d9d01